AJR Am J Roentgenol
- DIETRICH CF
Current Challenges of the Expanding Role of Contrast-Enhanced Ultrasound in
Hepatocellular Carcinoma Diagnosis Using LI-RADS.
AJR Am J Roentgenol. 2025 Jun 4. doi: 10.2214/AJR.25.33329.
Am J Gastroenterol
- CIRICILLO J, Myer A, Yeboah-Korang A, Osman A, et al
Improving the Diagnostic Accuracy of RECAM in North American Patients With
Suspected Idiosyncratic Drug-Induced Liver Injury.
Am J Gastroenterol. 2024;120:1325-1333.
- BARRITT AS 4TH, Hayashi PH, Stolz AA, Barnhart H, et al
Refinement of Hy Law Using the Drug-Induced Liver Injury Network Database.
Am J Gastroenterol. 2024;120:1307-1313.
- HUANG Y, Huang H, Wei T, Zhang A, et al
Disparities, Trends, and Predictions to 2040 in Gastrointestinal Cancer
Incidence, Mortality in the United States.
Am J Gastroenterol. 2024;120:1367-1380.
- QIAO Y, Yang L, Yang H, Zheng M, et al
Longitudinal Associations Between Metabolic Dysfunction-Associated Steatotic
Liver Disease and Subclinical Cardiovascular Measures in Chinese Children.
Am J Gastroenterol. 2024;120:1395-1399.
Biochem Biophys Res Commun
- NISHI H, Nakanishi S, Yamanaka D, Takahashi SI, et al
Apolipoprotein b transcription is driven by ornithine in hepatoma cell lines.
Biochem Biophys Res Commun. 2025;775:152076.
- HAN Y, Fan J, Xia W, Dong X, et al
Folic acid-functionalized PLGA nanomedicines encapsulating echinacoside for liver
cancer therapy.
Biochem Biophys Res Commun. 2025;774:152049.
BMC Gastroenterol
- ZHU H, Zheng M, Li W, Huang Y, et al
Cholesterol-modified prognostic nutritional index as an independent prognostic
biomarker in primary biliary cholangitis patients.
BMC Gastroenterol. 2025;25:421.
- TAN H, Xu Y, Zhang C, Zhong K, et al
Development and validation of a nomogram for predicting early recurrence in
patients undergoing different courses of postoperative adjuvant transarterial
chemoembolisation.
BMC Gastroenterol. 2025;25:422.
- XIA C, Liu Y, Qing X
Trends in incidence and mortality of early-onset gastrointestinal cancers: a
comprehensive study.
BMC Gastroenterol. 2025;25:424.
- DAI Y, Zeng M, He H, Cai M, et al
A risk prediction model for nausea and vomiting after TACE: a cross-sectional
study.
BMC Gastroenterol. 2025;25:427.
- SUI WF, Duan YX, Cai ZF, Li JY, et al
Quantitative literature analysis on efficacy and safety of balloon-occluded
transarterial chemoembolization for hepatocellular carcinoma.
BMC Gastroenterol. 2025;25:430.
Clin Res Hepatol Gastroenterol
- LEE CH, Kang MG, Oh S, Gwak IS, et al
Hepatocellular carcinoma risk in ICD-coded non-cirrhotic nonalcoholic fatty liver
disease refined by fatty liver index: A nationwide South Korean cohort study.
Clin Res Hepatol Gastroenterol. 2025;49:102612.
- SAIFI ES, Faita F, Nardin M, Orizio P, et al
Evaluation of long-term changes in liver function and structure in patients
exposed to SARS-CoV-2 infection: A prospective study.
Clin Res Hepatol Gastroenterol. 2025;49:102606.
- BEN YEDDER N, Girot P, Koudougou C, Schnee M, et al
Lack of prior screening for advanced liver fibrosis in patients with newly
diagnosed hepatocellular carcinoma: Results from a prospective multicentre study.
Clin Res Hepatol Gastroenterol. 2025;49:102607.
- JAIN P, Jain A, Deshmukh R, Samal P, et al
Metabolic dysfunction-associated steatotic liver disease (MASLD): Exploring
systemic impacts and innovative therapies.
Clin Res Hepatol Gastroenterol. 2025;49:102584.
- ZHANG C, Sun M, Ding Y, Yuan X, et al
Research progress on the regulatory role of different cell death pathways in
metabolic-dysfunction-associated steatotic liver disease.
Clin Res Hepatol Gastroenterol. 2025;49:102578.
Dig Dis Sci
- CHEN F, Zhou Z, Fu J, Gao C, et al
Selenomethionine Alleviates Alcohol-Induced Liver Injury by Inhibiting
Ferroptosis.
Dig Dis Sci. 2025;70:1779-1787.
- CAPINHA F, Carvalhana S, Cortez-Pinto H
Role of Alcohol in Steatotic Liver Disease: Impact on Patients with
Cardiometabolic Risk Factors.
Dig Dis Sci. 2025;70:1746-1756.
- BELCHER JM
Predicting the Use of Dialysis for Acute Kidney Injury in Patients with
Cirrhosis-Does Diagnosis Matter?
Dig Dis Sci. 2025 Jun 5. doi: 10.1007/s10620-025-09143.
- OWAIS M, Kumar D, Anjum A, Kumar J, et al
Clinical Insights on Characteristics and Outcomes of Hepatocellular Carcinoma in
Patients with Autoimmune Hepatitis.
Dig Dis Sci. 2025 May 31. doi: 10.1007/s10620-025-09124.
- LIU Y, Mo W, Sun W, Chen J, et al
NFAT2 Induces Tumor Cell Proliferation and Metastasis by Acting as a
Transcriptional Co-activator of the TGF-beta1/SMAD Signaling Pathway and Inducing
the Epithelial-Mesenchymal Transition in Liver Cancer.
Dig Dis Sci. 2025;70:1799-1812.
Eur Radiol
- GRIGORIADIS A, Bergquist A, Kartalis N
Shading light in the black box of hepatobiliary imaging.
Eur Radiol. 2025 Jun 6. doi: 10.1007/s00330-025-11740.
- PARK R, Kim DH, Choi SH, Kim J, et al
Preoperative scoring system for predicting microvascular invasion in intrahepatic
cholangiocarcinoma using gadoxetate-enhanced MRI.
Eur Radiol. 2025 Jun 6. doi: 10.1007/s00330-025-11722.
- ERLEY J, Naimi L, Molwitz I, Aydemir DG, et al
Novel insights into cardiac structure, function, perfusion, and tissue
characteristics in liver cirrhosis: a magnetic resonance analysis.
Eur Radiol. 2025 Jun 5. doi: 10.1007/s00330-025-11710.
Gut
- WANG C, Felli E, Fallowfield JA, Dietrich CF, et al
Vasomics of the liver.
Gut. 2025;74:1008-1020.
- LI S, Fu Y, Jia X, Liu Z, et al
NLRP6 deficiency enhances macrophage-mediated phagocytosis via E-Syt1 to inhibit
hepatocellular carcinoma progression.
Gut. 2025 Jun 5:gutjnl-2024-334448. doi: 10.1136/gutjnl-2024-334448.
- XING X, Wang SD, Yang JL, Wang Z, et al
Presinusoidal portal hypertension with cutaneous vascular malformations.
Gut. 2025 Jun 2:gutjnl-2025-335640. doi: 10.1136/gutjnl-2025-335640.
Hepatology
- LIANG BG, Zheng YM, Xu MH, Gao C, et al
The MASTL/YBX1/PAK4 axis regulated by stress-activated STK24 triggers lenvatinib
resistance and tumor progression in hepatocellular carcinoma.
Hepatology. 2025 Jun 2. doi: 10.1097/HEP.0000000000001392.
Indian J Gastroenterol
- PEMMADA V, Shetty A, Shetty S, C GP, et al
ABC score is a better predictor for 30-day mortality in upper gastrointestinal
bleeding: A prospective single-center study.
Indian J Gastroenterol. 2024 Dec 19. doi: 10.1007/s12664-024-01703.
- JOTHIMANI D, Marannan NK, Rela M
Acute liver failure and liver transplantation.
Indian J Gastroenterol. 2025;44:298-310.
J Gastroenterol
- ONO A, Hayes CN, Miura R, Kawaoka T, et al
Noninvasive prediction of the clinical benefit of immunotherapy in hepatocellular
carcinoma.
J Gastroenterol. 2025 May 30. doi: 10.1007/s00535-025-02251.
J Gastroenterol Hepatol
- GUO X, Wu L, Lai J, Wu Y, et al
Causal Associations Between Lipids, NPC1L1, and Liver Cancer Risk: Insights From
Mendelian Randomization and Bioinformatics.
J Gastroenterol Hepatol. 2025;40:1602-1615.
- XIA Y, Tie J, Wang G, Wu H, et al
Benefits of TIPS for Patients With Large Ascites Preceding Recurrent or
Refractory ascites: A Multicenter Cohort Study.
J Gastroenterol Hepatol. 2025;40:1574-1585.
- WANG L, Zhao Y, Duan B, Wang Y, et al
Iron Quantification Using Spectral CT-Based Material Decomposition Technique for
Noninvasive Hepatic Fibrosis Staging: An Experimental Study.
J Gastroenterol Hepatol. 2025 Jun 4. doi: 10.1111/jgh.17031.
- NIIZEKI T, Mawatari S, Shibata M, Sasaki R, et al
Comparison Analysis of Lenvatinib Plus Transcatheter Arterial Chemoembolization
Versus Atezolizumab Plus Bevacizumab as First-Line Therapy for Intermediate-Stage
Hepatocellular Carcinoma Beyond the Up-to-Seven Criteria.
J Gastroenterol Hepatol. 2025 May 31. doi: 10.1111/jgh.17024.
J Hepatol
- TAKEFUJI Y
Reevaluating Feature Selection in Machine Learning-Based Radiomics for
Hepatocellular Carcinoma: Bridging the Gap Between Predictive Accuracy and
Biological Relevance.
J Hepatol. 2025 May 29:S0168-8278(25)02258-5. doi: 10.1016/j.jhep.2025.
N Engl J Med
- SIMON TG
Semaglutide for Metabolic Dysfunction-Associated Steatohepatitis.
N Engl J Med. 2025;392:2160-2161.
PLoS One
- YOON J, Lee Y, Yoon S, Sung J, et al
Deep learning reconstruction of free-breathing, diffusion-weighted imaging of the
liver: A comparison with conventional free-breathing acquisition.
PLoS One. 2025;20:e0320362.
- RONG F, Cheng B, Guo L, Zeng S, et al
Correlation analysis of mitochondrial DNA maintenance-related genes with HCC
prognosis, tumor mutation burden and tumor microenvironment features.
PLoS One. 2025;20:e0325033.
- GRAF M, Graf C, Ziegelmayer S, Marka AW, et al
Complications of image-guided liver biopsies: Results of a nationwide database
analysis.
PLoS One. 2025;20:e0323695.
- YOO HW, Yang CJ, Yoo JJ, Chang Y, et al
Diagnostic performance of microvascular flow imaging for noninvasive assessment
of liver fibrosis in chronic liver disease.
PLoS One. 2025;20:e0322102.
- WU C, Chen X, Zhang Y, Du Y, et al
A novel ferroptosis-related signature for predicting prognosis, immune
characteristics, and treatment prediction in hepatocellular carcinoma.
PLoS One. 2025;20:e0322158.
- WEI B, Zheng Y, Yu S, Wang A, et al
Identification of key genes and signaling pathways of liver cancer and model
construction for prognosis and diagnosis based on bioinformatics analysis.
PLoS One. 2025;20:e0325610.
- LEE CW, Kang ES, Jeong S, Han HW, et al
Identification of potentially effective drugs for metabolic
dysfunction-associated steatotic liver disease against liver cirrhosis: In-silico
drug repositioning-based retrospective cohort study.
PLoS One. 2025;20:e0323880.
- MARGULIES BS, Likhitpanichkul M, Tripathy D
Reshaping the landscape of locoregional treatments for breast cancer liver
metastases: A novel, intratumoral, p21-targeted percutaneous therapy increases
survival in BALB/c mice inoculated with 4T1 triple negative breast cancer cells
in the liver.
PLoS One. 2025;20:e0323621.
- ORRIOLS G, Aljama C, Rodriguez-Frias F, Medina PG, et al
Quantification of serum elastase inhibitory activity in patients with pulmonary
emphysema with and without alpha-1 antitrypsin deficiency.
PLoS One. 2025;20:e0324237.
Radiol Imaging Cancer
- LI M, Zhang Z, Chen Z, Chen X, et al
Interactive Explainable Deep Learning Model for Hepatocellular Carcinoma
Diagnosis at Gadoxetic Acid-enhanced MRI: A Retrospective, Multicenter,
Diagnostic Study.
Radiol Imaging Cancer. 2025;7:e240332.
- SINGH Y, Gores GJ, Erickson BJ
Beyond the Black Box: Explainable AI Transforms Hepatocellular Carcinoma
Diagnosis at MRI.
Radiol Imaging Cancer. 2025;7:e250198.
Free Medical Abstracts
Privacy Policy
Sponsors
Share
© Amedeo 1997-2016